Cargando…

Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma

Detalles Bibliográficos
Autores principales: Ascione, Sophia, Harel, Stéphanie, Besson, Florent L., Belkhir, Rakiba, Henry, Julien, Royer, Bruno, Arnulf, Bertrand, Mariette, Xavier, Seror, Raphaèle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620568/
https://www.ncbi.nlm.nih.gov/pubmed/36951162
http://dx.doi.org/10.3324/haematol.2022.282214
_version_ 1785130233748258816
author Ascione, Sophia
Harel, Stéphanie
Besson, Florent L.
Belkhir, Rakiba
Henry, Julien
Royer, Bruno
Arnulf, Bertrand
Mariette, Xavier
Seror, Raphaèle
author_facet Ascione, Sophia
Harel, Stéphanie
Besson, Florent L.
Belkhir, Rakiba
Henry, Julien
Royer, Bruno
Arnulf, Bertrand
Mariette, Xavier
Seror, Raphaèle
author_sort Ascione, Sophia
collection PubMed
description
format Online
Article
Text
id pubmed-10620568
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-106205682023-11-03 Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma Ascione, Sophia Harel, Stéphanie Besson, Florent L. Belkhir, Rakiba Henry, Julien Royer, Bruno Arnulf, Bertrand Mariette, Xavier Seror, Raphaèle Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-03-23 /pmc/articles/PMC10620568/ /pubmed/36951162 http://dx.doi.org/10.3324/haematol.2022.282214 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letter to the Editor
Ascione, Sophia
Harel, Stéphanie
Besson, Florent L.
Belkhir, Rakiba
Henry, Julien
Royer, Bruno
Arnulf, Bertrand
Mariette, Xavier
Seror, Raphaèle
Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
title Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
title_full Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
title_fullStr Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
title_full_unstemmed Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
title_short Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
title_sort chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620568/
https://www.ncbi.nlm.nih.gov/pubmed/36951162
http://dx.doi.org/10.3324/haematol.2022.282214
work_keys_str_mv AT ascionesophia chemotherapyinsolitaryboneplasmacytomatopreventevolutiontomultiplemyeloma
AT harelstephanie chemotherapyinsolitaryboneplasmacytomatopreventevolutiontomultiplemyeloma
AT bessonflorentl chemotherapyinsolitaryboneplasmacytomatopreventevolutiontomultiplemyeloma
AT belkhirrakiba chemotherapyinsolitaryboneplasmacytomatopreventevolutiontomultiplemyeloma
AT henryjulien chemotherapyinsolitaryboneplasmacytomatopreventevolutiontomultiplemyeloma
AT royerbruno chemotherapyinsolitaryboneplasmacytomatopreventevolutiontomultiplemyeloma
AT arnulfbertrand chemotherapyinsolitaryboneplasmacytomatopreventevolutiontomultiplemyeloma
AT mariettexavier chemotherapyinsolitaryboneplasmacytomatopreventevolutiontomultiplemyeloma
AT serorraphaele chemotherapyinsolitaryboneplasmacytomatopreventevolutiontomultiplemyeloma